Article Information
History
- April 26, 2016.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Weidong Xiong1,
- Deisy Contreras1,
- Joseph Ignatius Irudayam1,
- Ayub Ali2,
- Otto O. Yang2,3 and
- Vaithilingaraja Arumugaswami1,4,5
- 1Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048,
- 2Departments of Medicine and Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles CA 90095.
- 3AIDS Healthcare Foundation, Los Angeles, CA 90028
- 4Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048,
- 5Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles CA 90095.
- Corresponding Author:
Vaithilingaraja Arumugaswami, MVSc., PhD., 8700 Beverly Blvd, AHSP, A8416, Los Angeles, CA 90048, Phone: +1 (310) 248 8584, FAX: +1 (310) 248 8066, Email: arumugaswami{at}cshs.org
Posted April 26, 2016.
C19ORF66 is an Interferon-Stimulated Gene (ISG) which Inhibits Human Immunodeficiency Virus-1
